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Abstract
Total stressed blood volume (SBVT ) and arterial elastance (Ea) are two a potentially impor-
tant, clinically applicable metrics for guiding treatment in patients with altered hemodynamic
states. Defined as the total pressure generating blood in the circulation, SBVT is a potential
direct measurement of tissue perfusion, a critical component in treatment of sepsis. Ea is closely
related to arterial tone thus provides insight into cardiac efficiency. However, it is not clinically
feasible or ethical to measure SBVT in patients, so a three chambered cardiovascular system
model using measured left ventricle pressure and volume, aortic pressure and central venous
pressure is implemented to identify SBVT and Ea from clinical data.
SBVT and Ea are identified from clinical data from six (6) pigs, who have undergone clini-
cal procedures aimed at simulating septic shock and subsequent treatment, to identify clinically
relevant changes. A novel, validated trend analysis method is used to adjudge clinically sig-
nificant changes in state in the real-time Ea and SBVT traces. Results matched hypothesised
increases in SBVT during fluid therapy, with a mean change of +21% during initial therapy,
and hypothesised decreases during endotoxin induced sepsis, with a mean change of -29%. Ea
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displayed the hypothesised reciprocal behaviour with a mean changes of -12% and +30% dur-
ing initial therapy and endotoxin induced sepsis, respectively. The overall results validate the
efficacy of SBVT in tracking changes in hemodynamic state in septic shock and fluid therapy.
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1 Introduction
Sepsis is a leading cause of intensive care unit (ICU) patient admission, comprising 10% of US ICU
admissions, and making septic shock the 10th ranked cause of death in the US at an estimated cost
of $16.7 billion and 215,000 lives annually [23], [12]. Patients who display significant cardiovascular
dysfunction in sepsis have a mortality rate of approximately 70-90%. There is thus a need for better
insight and care to improve outcome and cost.
Sepsis is defined as inappropriate systemic inflammatory response to infection resulting in ischemia,
hypotension, multiple organ failure, and potentially death. Treatment of sepsis and septic shock are
guided by the Surviving Sepsis campaign, which gives details on recommended treatment guide-
lines [9]. Until as recently, as 2016, this guide was based on an early goal-directed treatment,
which aimed to achieve specified metrics for patient outputs, including mean arterial pressure and
central venous pressure [15], through fluid infusions and various drug administrations. The ra-
tionale behind this approach is an increase in volume results in increased arterial pressure and
sustained tissue perfusion allowing organs to continue normal function. Early goal-directed treat-
ment has recently been shown to deliver no significant improvement in patient well-being [25], when
compared to previous guidelines, generating confusion and inconsistent requirements for treatment.
Currently, the surviving sepsis campaign guidelines recommend administrating 30ml/kg of flu-
ids in the initial resuscitation phase. However, as approximately only 50% of septic patients are
fluid responsive [3], inappropriate administration can result in increased mortality [22]. Accurately
monitoring patient specific response to receiving fluids is therefore critical to appropriate care, but
requires insight to patient condition not yet available [4].
Total stressed blood volume, SBVT , is defined as the total pressure generating blood volume in
the circulation [19]. It thus influences venous return and is a direct potential measure of tissue
perfusion. SBVT is the diference between the total blood volume in circulation and the unstressed
volume, where the unstressed volume is the minimum volume required to fill a blood vessel to the
point where it exerts a force on the vessel wall [30]. This definition makes SBVT a parameter of
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interest in sepsis patients. SBVT has recently been shown to be a potential index of fluid respon-
siveness [19],[27] showing a negative correlation between SBVT and cardiac output [27].
SBVT is difficult to measure directly and involves performing several cardiac arrests and vascular
fillings. As such it is impractical and unethical to perform this procedure in the ICU [20], and
thus the need for a model-based analogue is present. Finally, model based arterial elastance,Ea,
is also considered in this work due to its relation with unstressed volume, its relation to arterial
tone lost in septic shock, and the effect a change in this parameter can have on the efficiency of the
circulation [13].
A lumped three chambered cardiovascular system (CVS) model, first introduced by Pironet et
al, is implemented to develop model-based analogues of total stressed blood volume, SBVT , and
arterial elastance, Ea, in porcine subjects with induced septic shock. Real time monitoring of these
variables can provide a new insight into the state of the CVS during sepsis. Monitoring SBVT
could allow clinicians to move from a ’one size fits all’ goal pressure or set volume for fluid infusions
to a tailored patient specific treatment ’one method fits all’ approach, based on patient specific
progression of disease state and response to care [5].
This study aims to show how a three chambered CVS model can be used to monitor model based
analogues of SBVT and Ea. It aims to show how these metrics are effected under simulated septic
shock and fluid treatments, giving a first insight into the clinical applicability of these metrics.
2 Methods
2.1 Cardiovascular system model
The CVS model used in this work is a lumped, three-chambered model previously described by
Pironet et al [27],[28],[29], consisting of three elastic chambers connected via three flow resistances.
The chambers represent the left ventricle, lv, aorta, a, and one vena cava, vc, while the resistances
are indicative of an input, Ri, and output, Ro, cardiac resistance and the systemic circulation
resistance, Rc. The model is shown in Figure 1.
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Figure 1: Three-Chamber Model Schematic
The arterial and venous chambers are passive chambers with pressure in the chambers defined:
Pa(t) = EaVs,a(t) (1)
Pvc(t) = EvcVs,vc(t) (2)
where E is the chamber elastance and Vs is the stressed volume of the chamber. Stressed volume
is the difference between the total volume and the unstressed volume, Vu, in the chamber.
The left ventricular chamber is an active chamber described using a time varying pressure-
volume relationship [27],[37],[28]:
Plv(t) = e(t)ElvVs,lv(t) (3)
where Elv is the end systolic elastance of the left ventricle, Vs,lv(t) is the stressed volume and e(t) is
the normalised time-varying function derived following the work of Davidson et al. [7] and detailed
in the following section.
As stated, the chambers are linked through flow resistances Ri, Ro, and Rc representing the in-
put and output valve, and the systemic circulation resistance, respectively. Flow in the systemic
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where Rc is the value of the resistance of the circulation capturing the capillaries and surrounding
arterial-venous resistance. Flows in and out of the left ventricle are described by piecewise functions












if Pvl > Pa
0 otherwise
(6)
Calculating the flows from measured data and back calculation allows for properties such as viscosity
to be incorporated without the need for direct measurement. Finally, the continuity equation is
used to give the rate of change of volume for each of the chambers.
V̇S,c(t) = Qin,c −Qout,c (7)
where Qin,c and Qout,c represent the flow in and out of chamber c (c ∈ {a, vc, lv}). Summing the
rate of change of volume for all three chambers gives the total rate of change of stressed volume for
the system. As the system is treated as closed, the volume rate of change for the system is zero,
and thus the total stressed blood volume (Vs,3) is a constant defined:
Vs,lv(t) + Vs,vc(t) + Vs,a(t) = Vs,3(t) (8)
The complete system is thus defined through 8 model parameters (3 chamber elastances: Elv; Ea;
and Evc; 3 flow resistances: Ri; Ro; and Rc; the cardiac period, T ; and total stressed blood volume,
Vs,3), and a cardiac driver function e(t). Measured values for aortic pressure, left ventricle pressure,
left ventricle volume and central venous pressure are used to derive all necessary initial estimates
for the model parameters. Measured data is also used to construct error metrics corresponding to
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their representative parameters for parameter identification and validation.
2.2 Parameter Identification
As some parameters are not sensitive enough to be identified because of their relatively low impact
on the error function, a subset selection algorithm is used [29],[28]. Initial values for the model
parameters (Elv, Ea, Evc, Ri, Ro, Rc and SBVT ) are calculated [28] and passed through the subset
selection algorithm, which aims to select the set of parameters to be optimised by the parameter
identification method. This selection is completed using the Hessian matrix to evaluate the effect
each parameter has on the error vector and selecting a subset which can be optimised. The subset of
parameters selected were ({Elv, Ea, Evc, Ri, Rc, SBVT }). Parameter identification in this work was
completed using MATLAB’s (The Mathworks, Natick, MA, USA) fmincon function. The selected
subset was input to the function which minimized the error sum of squares of the parameters with
respect to their measured counterpart. Cardiac period (T ) is calculated directly from available
pressure waveforms.
2.3 Driver function model (e(t))
Time varying elastance (TVE) represents the active elastance in the cardiac chambers dictating
the heart’s contraction and expansion [7],[36]. TVE curves are derived using ventricular pressure
and volume waveforms and contain information which can be used to drive cardiovascular models.
Intrinsic to TVE curves is information pertaining to the stages of the cardiac cycle, such as filling,
isovolumetric contraction, and ejection. This information is vital in CVS models and TVE curves





where Vu is the unstressed volume in the left ventricle and Plv and Vlv are the left ventricle pressure
and volume, respectively. Previous work [7] has shown baseline Vu can be approximated as a fixed
percentage of the end-systolic volume (Ves), which allows an approximation of Vu during an initial
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echocardiographic calibration, in which Ves is available [7]. Thus, Vu can be expressed [6]:
Vu = 0.48× Ves (10)
The method used to derive the driver function in this work is described by Davidson et al [7] and
recreates pressure and volume waveforms using simple physiological assumptions combined with
readily available clinical measurements. Continuous measurements of aortic pressure (Pa) and heart
rate (HR), typically available in the ICU, in addition to baseline measurements of end-systolic (Ves)
and end-diastolic (Ved) volumes obtained from echocardiography readings are used to create patient
specific TVE curves. Thus, the method enables minimally invasive construction of TVE curves as
it removes the need for directly measured Plv and Vlv, which require highly invasive procedures and
additional catheters to obtain. It also avoids the need to directly assume the shape of the curve, as
done in previous methods [7], [36]. Finally, since finding SBVT only relies only on aortic (or distal)
arterial pressure and central venous pressure, it is non-additionally invasive in an ICU context as
it requires no additional catheters than are standard practice use for treating hemodynamically
unstable patients. This non-additional-invasiveness ensures a minimally to non- invasive method.
To approximate the Plv waveform the method assumes aortic valve resistance is negligible. As
a result, during the majority of systole, one can equate Plv to Pa, separated by some phase lag
due to the ventricle being located directly upstream of the aorta [7],[33],[35]. The Pa waveform
gives little information about the left ventricle during diastole, but left ventricular behaviour in this
region is known to be relatively passive [7]. As such, left ventricular pressure during diastole can
be modelled as a function consisting of two exponentials, an exponential increase for the beginning
of contraction and an exponential decay to a fixed value to model ventricular relaxation. Using
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Pa(t1 + δ < t < t2 + δ) t1 < t < t2
6 + (Pa(t2) − 6)e−17.5(t−t2) t2 < t < t3
Plv(t3) + (Pa(t4)− Plv(t3))e37.5(t−t4) t3 < t < t4
(15)
where δ = 0.008s. Timings detailed in Equations 11 - 14 indicate key positions of an aortic wave
used for the reconstruction of the left ventricle pressure wave. These positions are illustrated in
Figure 2(a) and show how information can be translated from measured waveforms to a simulated
waveform.
The Vlv waveform is recreated using a piecewise sine wave with a 90
◦ phase shift in conjunction
with 6 pieces of information derived from the aortic pressure waveform, 3 timings, t1, t2, t3, and 3
volumes, Vd, Ved, Ves, associated with diastole and systole. Previous work has shown end-systolic





Ved = Ves + SV (17)
where PDN is the aortic pressure at the dicrotic notch and HR and Ec represent heart rate and
an elastance coefficient, respectively. HR and Ec are used to define Ees and the cubic term in
Equation 16 allows for the best accuracy while maintaining low model complextity [8]. Finally, the









t1 < t < t2










t2 < t < t3
(18)
Where:
t1 = t(Pamin)n (19)
t2 = t(PDN )n (20)
t3 = t(Pamin)n+1 (21)
Timings detailed in Equations 19 - 21 indicate key positions on the nth aortic wave used for the
reconstruction of the left ventricle volume wave. These positions are illustrated in Figure 2 (b) and
show how information can be translated from measured waveforms to a simulated waveform.
(a) (b)
Figure 2: Estimated Plv and Vlv derived from invasively measured Pao
2.4 State Classification and Trend Monitoring
State classification in this work was performed using a modified version of the algorithm in [39] to
identify clinically relevant changes in SBVT and Ea during the experiment. This method calculates
the mean over an entire experiment or data series to establish a global mean. A 5 to 10 minute
centered rolling average of the data points is then calculated to remove the effects of any outliers
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in the data, which may have occurred during data collection [39]. This average was selected based
on clinically relevant time frames defining a clinically relevant state. The rolling average curves,
an example of which is depicted in Figure 3, are then compared to the global mean, and the in-
tercepts between the two curves (indicated by the blue circles) are noted. Each intercept between
the rolling average and the global mean is considered to determine if they are clinically relevant. If
the time between state changes is less than the rolling average time, this section of data is added
to the previous state and a new state average is calculated. Changes in state averages can then be
investigated to determine their correlation with any clinical procedures or events occurring during
that stage of the experiment.
The state analysis in this work performs two iterations to capture information, which may be
otherwise missed due to the length of the experiment and the inherent intra- and inter- subject
variability in subjects [11]. The second iteration is calculated the same, but uses each first iteration
states (purple lines) in place of the global average. Variations of the rolling average about these
states are considered with each intercept (purple circles) being checked for clinically relevant state
changes, as shown in Figure 3. The second iteration better differentiates rapid state changes as it
is considering the mean of certain subsections of the experiment and is also clinically defined. The
peak in Figure 4 between the first two original intercepts with the global mean is an example of
when fluctuations with duration less than that used for the rolling average occur, resulting in the
first and second iteration generating the same state.
Maas et al defined an increase in cardiac output > 12% as a positive response to a 500 ml fluid
therapy [19], clinically defining a state change. Thus, as this is a first study into changes in SBVT
and due to certain physiological similarities between SV and SBVT , a change in SBVT or Ea of
±10% is considered significant in this work for all state changes and defines a change of state in
response to fluid therapy and endotoxin infusion.
2.5 Experimental Data
The experimental protocol was approved by the Ethics Committee for the use of animals at the
University of Liege, Belgium. Six (6) pure Pietrain pigs were anaesthetised and mechanically
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Figure 3: Example of how the two stage state analysis is conducted with circled components
detailing the intercepts which are analysed to determine any state changes.
ventilated. Septic shock was then induced in the subjects via a one off infusion of endotoxin
(lipopolysaccharide from E. Coli, 0.5 mg/kg infused over 30 min). Pre-endotoxin infusion, a 500
mL saline solution is first administered over 30 min simulating fluid resuscitation therapy. Aortic
pressure in the subjects is continually measured via a catheter with a sampling rate of 250 Hz. Plv
and Vlv are also continually measured at a rate of 250 Hz via an admittance pressure volume catheter
inserted into the left ventricle via an apical stab. Measured SV is also compared to reinforce and
validate the trends and responses seen in the model-based SBVT , Ea metrics. In this work only
Pigs 1, 2, 4, 6, 7 and 8 are used due to errors in recording of data for the remaining subjects making
the data unsuitable for this model. Faults such a catheter being suspected of pressing up against
vessel walls and continuous shifts in data made Pigs 3 and 5 unreliable for this work.
2.6 Analyses
The outputs of this work displays a time series of modelled SBVT , Ea and directly measured
catheter values of SV. As shown in Figure 4, trends are observed through state changes, which
detail when a clinically defined change in the metrics occur and are depicted by horizontal dashed
lines. Output data is analysed to establish if displayed trends matched that hypothesised. It is
expected that:
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• A fluid infusion will result in a noticeable rise in SBVT ideally greater than 10%, indicating
a positive fluid response. Null or lesser changes would indicate fluid unresponsiveness.
• Inversely, it is expected Ea will decrease in response to a positive response to fluid infusion.
• Trends seen during or soon after sepsis is induced, via endotoxin infusion, are expected to be
the reverse of fluid infusions with SBVT dropping and Ea rising.
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3 Results
Figures 5 and 6 show the identified SBVT and Ea trajectories during an initial fluid resuscitation
therapy, induction of sepsis, and subsequent fluid infusions for all pigs. Also included in Figures
5 and 6 is catheter measured SV, which is commonly used in investigations of fluid responsiveness
and is also physiologically similar to SBV, thus provides a meaningful comparison. For clarity, data
points on the figures show results for every 100th heart beat. Vertical lines are indicative of the
start and end of each the various procedures with the colour indicating which procedure is being
performed. Figure 4 shows the iterative state analysis to identify trends in subject responses for
a single subject. State averages are represented by horizontal dashed lines and represent when a
clinically relevant change in the modelled parameter has occurred. The two staged state identifi-
cation process employed ensures smaller, more rapid, responses are not overlooked.
Tables 1 - 3 detail the numerical state average changes for the corresponding parameters. Results
generally matched hypothesised behaviours, with SV BT having mean increase of +21% during
initial filling and falling with a mean of -29% in endotoxin induced sepsis. Ea shows similar results
in reverse, as hypothesised. For subjects that survived the endotoxin infusion (Pigs 2, 6 and 7),
further fluid therapies were administered. The results are also displayed in Tables 1 - 3. Pigs
which have not displayed any fluctuation around the global average are displayed as a dash (-)
while deceased Pigs are denoted with a ’D’, indicating no further data follows. Values in red text
represent where a change in the metric has occurred but is below the ±10% threshold.
Tables 1 - 3 show the collated results for iterative state analysis across all subjects. It details
the percentage increase or decrease in response to the associated clinical procedure. A dash implies
no state change was observed either due to no effect being seen or the response to the procedure
was smaller than the clinically specified 10% limit and thus not considered clinically relevant [19].
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Figure 4: Example result of State Analysis for each variable of Pig 7. Horizontal lines indicate
state changes while vertical lines represent timings of fluid therapies: First (Red); Second (Blue);
Third (Black); and endotoxin infusion (Green).
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Figure 5: Changes in model based analogues of SBVT (◦) and Ea (x) and measured SV (∗) with
respect to various clinical procedures of Pigs 1 (TOP), 2 (MIDDLE) and 4 (BOTTOM). Vertical
lines represent timings of fluid therapies: First (Red); Second (Blue); Third (Black); and endotoxin
infusion (Green).
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Figure 6: Changes in model based analogues of SBVT (◦) and Ea (x) and measured SV (∗) with
respect to various clinical procedures of Pigs 6 (TOP), 7 (MIDDLE) and 8 (BOTTOM). Vertical
lines represent timings of fluid therapies: First (Red); Second (Blue); Third (Black); and endotoxin
infusion (Green).
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SBVT (Fill 1) SBVT (Endo) SBVT (Fill 2) SBVT (Fill 3)
Pig 1 +22% - D D
Pig 2 +4.6% -23% +17% -10%
Pig 4 +22% -39% D D
Pig 6 +11% -26% -12% -
Pig 7 +42% -33% +10% +15%
Pig 8 +24% -55% D D
MEAN +21% -29% +13% +8.3%
Table 1: Relative change in SBVT during clinical procedures.
Ea (Fill 1) Ea (Endo) Ea (Fill 2) Ea (Fill 3)
Pig 1 -9.0% - D D
Pig 2 -29% +81% -4.6% -7.8%
Pig 4 -19% - D D
Pig 6 - +24% +25% +10%
Pig 7 -16% +15% +14% +15%
Pig 8 - +60% D D
MEAN -12% +30% +8.3% +5.7%
Table 2: Relative change in Ea during clinical procedures.
SV (Fill 1) SV (Endo) SV (Fill 2) SV (Fill 3)
Pig 1 +25% - D D
Pig 2 +20% -19% +19% +8.5%
Pig 4 +20% -52% D D
Pig 6 +22% -32% +26% -
Pig 7 +25% -32% +4.3% +14%
Pig 8 +22% -60% D D
MEAN +22% -33% +16% +7.5%
Table 3: Relative change in SV during clinical procedures.
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4 Discussion
This work introduces two model based analogues for Total Stressed Blood Volume (SBVT ) and ar-
terial Elastance (Ea) derived using the presented three chamber model. The model used measured
values for aortic pressure, left ventricle pressure and volume and central venous pressure to derive
SBVT and Ea. This work deems these parameters significant due to their representation of tissue
perfusion and arterial tone, respectively. However, direct measurements of these values are unable
to be conducted in an ICU resulting in the need for model based analogues.
Positive responses to fluid therapy have previously been clinically defined by a change in cardiac
output of greater than 12% [19] and is the desired outcome of a fluid infusion. Due to variability
in subjects and the differing procedures performed, this work considers a state average change of
2×±5% to be clinically significant. This multiplication is due to the two part iteration of the state
analysis. Administering fluids aims to increase cardiac output by increasing the total volume, and
thus an increase in SBVT is expected. If no increase in SBVT is detected from fluid filling it would
suggest some CVS dysfunction and potentially increased vascular permeability leading to tissue
hypoperfusion. Equally, no response may be due to the subject not being hypovolemic, resulting
in excess fluid, which can appear in the lungs causing ventilation difficulties [22],[21],[32].
4.1 Stressed Blood Volume
During the initial fluid therapy, a state average increase of SBVT occurs in all subjects, with an
average increase of 20.9%. This result indicates these subjects experienced a positive response to
the fluid infusion. Due to the fluid infusions being administered pre-endotoxin, positive responses
are expected, as the subjects are still considered healthy, and may also explain why such substantial
increases are present due to no CVS dysfunction being present yet to cause fluid loss. Similarly,
Pigs 1, 6 and 7 display a decrease in SBVT towards the end of this procedure, which may be due
to the fluid therapy being conducted on a healthy subject, where excess fluid is unnecessary, or less
necessary, and therefore fluid overload may have occurred. In this circumstance, it is possible a
hypervolemic state is induced forcing fluid into the interstitial space and seen as a drop in SBVT [38].
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With the exception of Pig 1, Table 1 shows all subjects experience a state average decrease of
SBVT in response to the endotoxin infusion, as hypothesised and expected. A mean state decrease
in SBVT of -26% is seen in response to endotoxin, indicating significant complications in the cardio-
vascular system. Pig 1 also shows a decrease in this section, but insufficient survival time for this
subject means a state change in SBVT is not found, although it’s evident in the end of Figure 5.
As septic shock is induced fluid is lost from the circulation due to increased vascular permeability
[24], [14]. The loss in total volume would result in a drop in blood pressure and SBVT , which are
both characteristic of septic shock [21], [14],[18],[31] and evident in this experiment.
Post endotoxin infusion, 3 subjects, Pigs 2, 6 and 7, received further fluid therapies allowing for
monitoring of parameters during a simulated clinical response to septic shock. During the first
post-endotoxin fluid therapy Pigs 2 and 7 saw a state increase in SBVT indicating a positive re-
sponse to treatment. The effects of treatment in both pigs can be seen to hold until the second
post-endotoxin fluid therapy, where there is a disparity in the responses. While Pig 7 displays an
initial increase in SBVT during filling, a drop midway through is indicative of a natural response to
fluid overload. Fluid overload commonly causes a drop in SV and CO and exacerbates the effects
of sepsis on the cardiovascular system [21],[1],[2],[17]. Thus, a corresponding drop in SBVT would
also be expected given this condition. Pig 2 displays a similar trend to Pig 7 with a decrease in
SBVT part way through filling, but with no initial increase in observed.
Smaller responses in SBVT are seen for Pigs 2 and 6 which may be due to the starting point
of the experiment and the prior data available for analysis. Pigs 2, 6 and 8 have an initial fluid
therapy shortly after the start of the experiment due to positioning issues with equipment rendering
prior recordings difficult to use. Due to the nature of the state change analysis and the relatively
short time before fluid therapy, a smaller response may occur.
4.2 Arterial Elastance
Pig 6 is the only subject to have no discernible positive response to fluid therapy post endotoxin.
Both the second and third fluid therapies post-endotoxin cause a slight increase in SBVT , but the
effects are brief, and, in both cases, begin to drop before the end of the treatment. This outcome
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indicates the subject was not fluid responsive in either case, which is likely due to a severe reaction
to endotoxin and/or the subject is simply not fluid responsive.
Ea during initial fluid therapy either decreased or saw no change in state averages for all sub-
jects. As this therapy is first performed on a healthy subject it is expected there would be little
effect on the elastance as endotoxin has yet to initiate any issues in the system or arterial tone. A
decrease in Ea may also be in response to the volume administered, with the blood vessels relax-
ing to accommodate this extra fluid. If sepsis were affecting the properties of the arterial system
causing an increase in stiffness, a rise in Ea during or soon after the endotoxin infusion would be ex-
pected. Due to the variability in biological systems it is expected subjects will respond to endotoxin
differently [10]. Thus, the time during and immediately following endotoxin infusion are considered.
In general, Ea showed a state increase in response to endotoxin infusion, as expected. A mean
increase of 36% over the 5 Pigs (Pigs 2, 4, 6, 7 and 8) to survive past endotoxin administration
was found. The 2 Pigs that do not display a state change in Ea in response to endotoxin (Pigs 2
and 4) had severe reactions and died immediately after (Pig 4) or during (Pig 2) the procedure.
Maintaining appropriate blood pressure in subjects with sepsis is of vital importance and stiffening
of the arterial/venous tone is one means of regulating this pressure in hypovolemic states. The two
pigs which had a severe reaction may have done so due to an inability to increase Ea to maintain
adequate blood pressure, as a sign of the body fighting back. Early, rapid death of Pigs 2 and 4
meant insufficient time was available for a state change to be calculated [39].
During the two post-endotoxin fluid therapies, Pigs 6 and 7 showed state average increases in
Ea. These results are consistent with the response seen in SBVT during this time, again suggest-
ing and supporting the conclusion these subjects were not fluid responsive. Pig 2 also displays a
trend in Ea consistent with changes seen in SBVT . During both post-endotoxin fluid therapies, Ea
experiences a state drop, indicating the fluid is having a positive and expected effect.
In conjunction with the two parameters identified from the model (SBVT , Ea), catheter measured
SV was also monitored for the corresponding heartbeats as a form of validation. As expected,
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trends in SV closely resemble those of SBVT , but also provide additional information of interest.
All subjects see a state average increase during the initial fluid with a mean increase of 22.5%, which
is again expected due to the CVS still considered healthy and no infection present. Pigs 1, 6 and 7
show a decrease in SV at the end of filling, reinforcing the judgement that fluid overload is occurring
in these subjects. Significant decreases in SV are seen in all subjects, with the exception of Pig 1,
which died prior to the completion of endotoxin. A mean state average decrease of 39% across the
surviving pigs validates the fact induced sepsis has a severe impact on SV, as seen clinically [23],[12].
Post-endotoxin fluid infusions show SV is generally more sensitive to fluid therapy than SBVT
and displays a faster response to treatment. All surviving subjects had increases in SV from the
first filling post-endotoxin, but Pig 7 displayed only a small increase which appeared to maintain
SV at the current level, rather than provide any significant increase. Pig 2 experiences a posi-
tive response in SV from the second post-endotoxin filling, which is in contrast to the negative
response in SBVT . However, while SV is more sensitive, SBVT may be the better clinical measure
if performance improvement is the primary goal of fluid therapy.
4.3 Limitations
One of the biggest limitations of the model presented in this work is it only encompasses the sys-
temic circulation and omits the pulmonary circulation [27],[28]. The underlying assumption here
is the systemic and pulmonary circulations can be treated separately, which is not physiologically
accurate. Only considering the systemic circulation also means there is no ventricular interac-
tion. In the body, the heart is enclosed a fibrous membrane called the pericardium, which causes
a compressive force applied to the left ventricle when the right undergoes filling. With only one
circulation being considered this interaction cannot be accounted for, though it is typically small
except in pulmonary embolism [33],[34].
Physiologically the left ventricle and parts of the arterial and venous systems are located in the
thoracic chamber, which results in a thoracic pressure being applied to part of the systemic cir-
culation. Again, as only one circulation is accounted for in this model it is difficult to accurately
account for this pressure. Thoracic pressure effects the right ventricle differently to the left, and
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this effect cannot be properly recreated here. Anatomically, parts of the passive arterial and venous
chambers are also located in the thoracic chamber making the resulting effect difficult to account
for. However, this influence likely only applies a small consistent bias, where the trends over treat-
ment are potentially more clinically important.
A noticeable difference in the model to true anatomy is the absence of an atrium, which pro-
videds part of the pressure required to fill the ventricle. It has not yet been shown that the time
varying elastance theory can be applied to the atria as it is done to the ventricle. Other authors
have developed alternate methods to represent the atria such as the multi-scale model [26]. How-
ever, the large number of parameters required for such methods to work cannot be identified using
the limited data clinically available, making it unsuitable to apply in this work. Although the atria
is excluded from the model, model parameters can be adjusted to account for this absence. Filling
of the left ventricle is represented as a passive process thus, Ri, the parameter describing the flow
resistance into the ventricle, will likely be lower than reality to compensate for no atria, providing
a totally passive equivalent filling.
Finally, this study is limited by the small sample size of experimental data available. Although
limited in number, the porcine data used in this study provided accurate information to run and
validate the model, including left ventricle volume, which is not typically available in the ICU. Such
animal studies are intensive, time consuming, and costly, thus the number can be limited. However,
the quality of data available for validation is very high, and unavailable in human subjects. Thus,
this study and data provide a foundation of work, which can be confidently built on to investigate
trends in a larger population of human subjects, while directing it towards a clinical setting.
4.4 Conclusion
The work presented in this paper used measured aortic, central venous and left ventricular pressure
and volume to provide information for the model. The model presented in this work outputs a
set of parameters two of which, SBVT and Ea, are potentially important metrics of fluid respon-
siveness. Although some of this measured data is currently available in the ICU, measured left
ventricular volume is typically not accessible and pressures are not usually measured in the direct
23
locations used here. Future work would employ emerging methods [16] to capture SV from dias-
tole pressure measures and thus use currently available ICU data, avoiding the need for any new
procedures/devices to be implemented.
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